Advertisement

Topics

mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.

2016-09-25 21:49:08 | BioPortfolio

Published on BioPortfolio: 2016-09-25T21:49:08-0400

Clinical Trials [2388 Associated Clinical Trials listed on BioPortfolio]

Mobile Cardiovascular Risk Service Trial

Risk factors for cardiovascular disease are poorly controlled even for patients who frequently visit their physician, leading to large numbers of preventable cardiovascular events such as ...

Primary Care Audit of Global Risk Management

1. Assessing the perception of Canadian Primary Care Physicians towards global cardiovascular risk assessment. 2. Correlating physician perceptions to actual practice data, gathere...

Neighborhood Environments and Cardiovascular Disease

To investigate the contributions of neighborhood environments to the distribution of cardiovascular disease (CVD) risk across different age ranges and racial/ethnic groups, using data from...

NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health

The purpose of the study is to investigate the preservation or promotion of health in students during the college years.

Verizon mHealth Solution for Patients With Peripheral Artery Disease (PAD)

The purpose of this study is to understand the effects that a six month lifestyle-based mobile health (mHealth) peripheral artery disease (PAD) prevention program will have on improving ph...

PubMed Articles [32269 Associated PubMed Articles listed on BioPortfolio]

Current and future cardiovascular disease risk assessment in the European Union: an international comparative study.

Risk assessment is central to primary prevention of cardiovascular disease (CVD), but there remains a need to better understand the use of evidence-based interventions in practice. This study examines...

Statins in primary prevention of cardiovascular disease.

Cardiovascular events are the second leading cause of death in France. The assessment of overall cardiovascular risk using a personalized assessment with weighting risk factors can predict the risk of...

Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.

Chronic kidney disease (CKD) is a global health burden and is independently associated with increased cardiovascular disease risk. Assessment of cardiovascular risk in the general population using pro...

Novel combined index of cardiometabolic risk related to periarterial fat improves the clinical prediction for coronary artery disease complexity.

Cardiovascular (CV) risk assessment based on conventional risk factors has a limited performance in the prediction of obstructive coronary artery disease (CAD). Therefore, our aim was to provide a com...

Rheumatoid arthritis and risk of cardiovascular disease.

In developing countries, rheumatoid arthritis (RA) remains a seriously under-prioritised disease, particularly among the underprivileged, often resulting in presentation of patients late in the course...

Medical and Biotech [MESH] Definitions

Restoration of functions to the maximum degree possible in a person or persons suffering from a CARDIOVASCULAR DISEASE. It also includes cardiac conditioning and SECONDARY PREVENTION in patients with elevated cardiovascular risk profile.

A specialty concerned with the nursing care of patients suffering from disorders of the CARDIOVASCULAR SYSTEM as well as those identified as at risk for adverse cardiac or vascular events.

The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

ANGINA PECTORIS or angina-like chest pain with a normal coronary arteriogram and positive EXERCISE TEST. The cause of the syndrome is unknown. While its recognition is of clinical importance, its prognosis is excellent. (Braunwald, Heart Disease, 4th ed, p1346; Jablonski Dictionary of Syndromes & Eponymic Diseases, 2d ed). It is different from METABOLIC SYNDROME X, a syndrome characterized by INSULIN RESISTANCE and HYPERINSULINEMIA, that has increased risk for cardiovascular disease.

A major and the second most common isoform of apolipoprotein E. In humans, Apo E4 differs from APOLIPOPROTEIN E3 at only one residue 112 (cysteine is replaced by arginine), and exhibits a lower resistance to denaturation and greater propensity to form folded intermediates. Apo E4 is a risk factor for ALZHEIMER DISEASE and CARDIOVASCULAR DISEASES.

More From BioPortfolio on "mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina."

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial